Efficient generation of human NOTCH ligand-expressing haemogenic endothelial cells as infrastructure for in vitro haematopoiesis and lymphopoiesis
DOI: 10.1038/s41467-024-51974-7
Authors: Shicheng Sun; Ali Motazedian; Jacky Y. Li; Kevin Wijanarko; Joe Jiang Zhu; Kothila Tharmarajah; Kathleen A. Strumila; Anton Shkaruta; L. Rayburn Nigos; Jacqueline V. Schiesser; Yi Yu; Paul J. Neeson; Elizabeth S. Ng; Andrew G. Elefanty; Edouard G. Stanley
Step 1: iPSC/ESC maintainance
day 0 ~ 1
culture “adherent” human PSC in “E8” for “1” days. For ECM, use “Geltrex” at “1” “%”. Medium should be changed once in “1” days.
Ideally, “PSC” should be obtained at the end of culture.
Step 2: Primitive streak 1
day 1 ~ 2
culture “adherent” human PSC in “unspecified medium” for “1” days. For ECM, use “Geltrex” at “1” “%”. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| Activin A | 3.0e-5 | g/l |
| CHIR90021 | 4.0e-6 | mol/l |
| FGF | 2.0e-5 | g/l |
| PIK90 | 1.0e-7 | mol/l |
| Y27632 | 1.0e-5 | mol/l |
Ideally, “PS” should express “MIXL1” at the end of culture.
Step 3: Primitive streak 2
day 2 ~ 3
culture “adherent” human PSC in “unspecified medium” for “1” days. For ECM, use “Geltrex” at “1” “%”. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| A83-01 | 1.0e-6 | mol/l |
| CHIR90021 | 3.0e-6 | mol/l |
| LDN193189 | 2.5e-7 | mol/l |
| FGF | 2.0e-5 | g/l |
Step 4: mesoderm 1
day 3 ~ 4
culture “adherent” human PSC in “unspecified medium” for “1” days. For ECM, use “Geltrex” at “1” “%”. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| BMP4 | 3.0e-5 | g/l |
| A83-01 | 1.0e-6 | mol/l |
| VEGF | 5.0e-5 | g/l |
| FGF | 2.0e-5 | g/l |
Ideally, “mesoderm” should express “CD13”, “KDR” at the end of culture.
Step 5: endothelial 1
day 4 ~ 6
culture “adherent” human PSC in “unspecified medium” for “2” days. For ECM, use “Geltrex” at “1” “%”. Medium should contain factors shown in the following table, and should be changed once in “2” days.
| concentration | unit | |
|---|---|---|
| SCF | 5.0e-5 | g/l |
| VEGF | 5.0e-5 | g/l |
| BMP4 | 1.0e-5 | g/l |
| FGF | 5.0e-5 | g/l |
Ideally, “EC” should express “DLL4”, “CXCR4”, “CDH5”, “CD34”, “PECAM1”, “SOX17”, “GJA4”, “GJA5” at the end of culture.
Step 6: endothelial 2
day 6 ~ 8
culture “adherent” human EC in “unspecified medium” for “2” days. For ECM, use “Geltrex” at “1” “%”. Medium should contain factors shown in the following table, and should be changed once in “2” days.
| concentration | unit | |
|---|---|---|
| SCF | 1.0e-4 | g/l |
| VEGF | 5.0e-5 | g/l |
| FGF | 5.0e-5 | g/l |
| IL3 | 1.0e-5 | g/l |
| FLT3-L | 1.0e-5 | g/l |
| FGF | 2.0e-5 | g/l |
| IL7 | 1.0e-6 | g/l |
Ideally, “EC” should be obtained at the end of culture.